About the Author |
| Mary Lou Oster-Granite, Ph.D., joined the MRDD Branch as a Health Scientist Administrator in July 1999. Dr. Oster-Granite received her doctorate in anatomy/neuroanatomy from the Johns Hopkins University and completed a postdoctoral fellowship in developmental neurovirology at the Johns Hopkins University School of Medicine. A long-time grantee of the NIH, and NICHD particularly, Dr. Oster-Granite held faculty positions at the University of Maryland School of Medicine and at Johns Hopkins University School of Medicine and served as a tenured professor of biomedical sciences at the University of California at Riverside before joining the Branch. As a developmental neuroembryologist, neurovirologist, and neurogeneticist, her research interests include genetic models of MRDD, and most recently, animal models of Down syndrome and ornithine carbomyl transcarbamylase deficiency. Her programmatic interests include brain function at a cellular/molecular level, developmental neurobiology, neurochemistry, neurovirology, molecular genetics, and gene therapy. From May 2003 to December, 2005, Dr. Oster-Granite served as acting Branch chief.
Travis Thompson, Ph.D., is Professor of the Autism Program of the Department of Pediatrics at the University of Minnesota School of Medicine; a faculty affiliate of the University of Minnesota's Center on Neurobehavioral Development; and he serves as Supervising Psychologist for the Minnesota Early Autism Project, a community-based treatment program for young children with autism spectrum disorders (ASD).
|
|
Summary
8 hours CE
Edited by Stephen R. Schroeder, Mary Lou Oster-Granite, and Travis Thompson
This a comprehensive, interdisciplinary review of the research on etiology and treatment of this chronic condition for which there is no known apparent cure. With an estimated prevalence rate of 13%, SIB occurs most frequently among persons who are retarded and autistic. In this volume, the fieldís leading researchers examine a new generation of models and theories with a level of specificity far beyond what was heretofore imagined possible. From the burgeoning area of research on functional assessment and the behavioral and biological antecedents of SIB, to the role of Lesch-Nyhan Syndrome and opioid peptides, the work of these foremost basic, applied, and behavioral researchers is sure to greatly enhance fellow researchersí, teachersí, and cliniciansí understanding of this devastating condition.
Learning Objectives
- List characteristics of self-injurious behavior (SIB)
- Identify environmental determinants of SIB
- Name medications that have demonstrated efficacy in treating SIB
- Name core characteristics of Lesch-Nyhan syndrome
- Identify models for managing SIB in clinical practice
Difficulty Level: Intermediate
405pp
Return to Catalog
|
